home / stock / ibio / ibio news


IBIO News and Press, iBio Inc. From 10/02/23

Stock Information

Company Name: iBio Inc.
Stock Symbol: IBIO
Market: NYSE
Website: ibioinc.com

Menu

IBIO IBIO Quote IBIO Short IBIO News IBIO Articles IBIO Message Board
Get IBIO Alerts

News, Short Squeeze, Breakout and More Instantly...

IBIO - iBio Explains Recent Filing of Registration Statement

BRYAN, Texas and SAN DIEGO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- In response to investor inquiries received about the post-effective amendment to its Form S-3 on Form S-1 (the “Post-Effective Amendment”) filed on Friday, September 29, 2023 with the United States Securities and Exchange...

IBIO - iBio Announces Filing of 2023 Annual Report on SEC Form 10-K

BRYAN, Texas and SAN DIEGO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced today the filing of its annual report on Form 10-K with the United States Securitie...

IBIO - iBio extends credit maturity deadline to complete pending sale of manufacturing facility

2023-09-21 16:38:15 ET More on iBio Seeking Alpha’s Quant Rating on iBio Historical earnings data for iBio Financial information for iBio For further details see: iBio extends credit maturity deadline to complete pending sale of manufacturing facility

IBIO - iBio Announces Amendment to Credit Agreement with Woodforest

– Extends maturity date to December 31, 2023 – – Allows time to close pending sale of CDMO facility – BRYAN, Texas and SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven inno...

IBIO - iBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical Development

– AI-powered technology enables rapid, simultaneous progress of antibodies against challenging targets – BRYAN, Texas and SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovato...

IBIO - iBio appoints CEO, CFO

2023-06-27 08:30:10 ET Precision antibody immunotherapies company iBio ( NYSE: IBIO ) said on Tuesday that Martin Brenner has been appointed CEO and Felipe Duran CFO, effective immediately. Brenner will also continue on the role of chief scientific officer. ...

IBIO - iBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company's Next Stage of Growth

– Board appointments solidify management team to lead iBio’s AI-powered biotech strategy – BRYAN, Texas and SAN DIEGO, June 27, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precis...

IBIO - 3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever

2023-06-20 08:25:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Even the most conservative investor hopes to find that one stock that can make them millions. That’s why they look at the biotech sector. One “home run” drug or therapeut...

IBIO - Why Is Manchester United (MANU) Stock Up 11% Today?

2023-06-13 10:06:03 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Manchester United (NYSE: MANU ) stock is rising on Tuesday as word spreads that Sheikh Jassim bin Hamad al-Thani may take over the company . According to recent reports ...

IBIO - Why Is iBio (IBIO) Stock Up 16% Today?

2023-06-13 09:40:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ibio (NYSEMKT: IBIO ) stock is rising higher on Tuesday as investors react to the company reaching a research collaboration agreement with the National Institutes of Health ...

Previous 10 Next 10